Progress of Azole Antifungal Agents
Weida Liu
Abstract
Weida Liu
Abstract
In recent years, some new azole antifungal agents have been developed, including oral and topical preparations, such as voriconazole, ravuconazole and posaconazole for oral use as well as sertaconazole, sulconazole and tioconazole for topical use. These new azoles present a broader antifungal spectrum and a more effective antifungal activity. They also have shown a good prospect in the preliminary clinical practice, especially the systemic antifungal agents. This review summarizes the current advance in clinical use of new azoles.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In recent years, some new azole antifungal agents have been developed, including oral and topical preparations, such as voriconazole, ravuconazole and posaconazole for oral use as well as sertaconazole, sulconazole and tioconazole for topical use. These new azoles present a broader antifungal spectrum and a more effective antifungal activity. They also have shown a good prospect in the preliminary clinical practice, especially the systemic antifungal agents. This review summarizes the current advance in clinical use of new azoles.
Key concepts: Posaconazole, Azole, Voriconazole, Antifungal, Medicine, Fluconazole, Itraconazole, Intensive care medicine